The biochemistry analyzers market has witnessed significant growth over the past few years due major applications of biochemistry analyzers in clinical laboratories, hospitals and point of care testing. Biochemistry analyzers helps in performing several diagnostic tests efficiently along with automation. It allows analyzing blood, urine and other body fluids with high accuracy and precision. Some key advantages of biochemistry analyzers are reduced turnaround time of test results, high throughput of samples and eliminate human errors. The growing prevalence of chronic and infectious diseases has increased the demand for diagnostic testing which drives the growth of biochemistry analyzers market.

Global biochemistry analyzers market is estimated to be valued at US$ 4,362.1 million in 2023 and is expected to exhibit a CAGR of 5.9% during the forecast period (2023-2030). 

Key Takeaways

Key players operating in the biochemistry analyzers market are Thermo Fisher Scientific, Roche Diagnostics, Siemens Healthcare, Panasonic Healthcare Holdings, Beckman Coulter, Abbott Laboratories, Ortho Clinical Diagnostics, Randox Laboratories.

The increasing awareness of early disease diagnosis and the growing geriatric population have raised the Biochemistry Analyzers Market Demand, driving the growth of diagnostic testing.

Technological advancements in biochemistry analyzers such as high-throughput systems, automated analyzers, random access systems have increased efficiency and productivity which is fueling the market growth.

Market Trends

Point of care (POC) testing is gaining popularity owing to real-time results and ease of operation outside the central labs. This has led to increased adoption of portable biochemistry analyzers.
Growing demand for automated analyzers as they minimize manual errors and reduce turnaround time of diagnostic reports. Automated biochemistry analyzers allows multiple tests to run simultaneously in random order.

Market Opportunities

Emerging economies present lucrative opportunities for biochemistry analyzers market players owing to increasing healthcare expenditures and rising awareness.
Growing demand for integrated biochemistry analyzers having features like LIS connectivity, sample sorting, barcode reading etc. offers scope for development of advanced analyzers.

Impact of COVID-19 on Biochemistry Analyzers Market

The COVID-19 pandemic has significantly impacted the biochemistry analyzers market globally. During the initial outbreak, most countries imposed complete lockdowns to curb the virus spread. This led to temporary suspension of non-essential medical procedures and diagnostic tests. As a result, demand for biochemistry analyzers from hospitals and diagnostic labs witnessed a steep decline in 2020. However, with governments making efforts to ramp up testing, the demand started recovering from mid-2020. Also, launch of several initiatives to strengthen healthcare infrastructure supported market recovery.

Going forward, demand is expected to rise steadily as regular diagnostic services resume full capacity. However, supply chain disruptions caused due to lockdowns continue to hamper market growth. Manufacturers are focusing on minimizing disruptions by diversifying supplier base and investing in developing inventory. Rising awareness about maintaining good health is prompting people to get routine health checkups even during pandemic. This will drive demand for advanced diagnostic solutions including biochemistry analyzers in the long run.

In terms of value, North America dominated the market and held around 35% share in 2019. Rising cases of lifestyle diseases coupled with availability of advanced healthcare facilities support market growth in the region. Asia Pacific is the fastest growing regional market, expanding at a CAGR of over 7% between 2023-2028. Rising healthcare expenditure, growing medical tourism, and increasing focus of global market players on gaining foothold in emerging countries are fueling market growth in Asia Pacific. Growing geriatric population, improving access to diagnostic facilities are other key aspects propelling market growth across major Asian countries including China and India.

Europe holds significant share in global biochemistry analyzers market. Major European countries including Germany, U.K, France hold leading position owing to high adoption rates of advanced diagnostic technologies. Major market players have established presence across Europe, facilitating technology advancements and market growth. Besides, countries have universal healthcare coverage supporting diagnostic tests demand. Favorable government policies are promoting biomedical industry growth across countries.

Get More Insights – Biochemistry Analyzers Market

Get This Report in Japanese Language –生化学分析装置市場

Get This Report in Korean Language -생화학 분석기 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)